Close
4

Seqens Seqens

X

Company profile for Cadrenal Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
We are a clinical-stage biopharmaceutical company focused on advancing the development of our lead drug candidate, tecarfarin, a late-stage novel therapy with orphan drug indication for the prevention of systemic thromboembolism in patients with end-stage renal disease and atrial fibrillation. We are committed to bringing this novel therapy to the market to help improve the lives of the thousands of individuals who suffer fr...
We are a clinical-stage biopharmaceutical company focused on advancing the development of our lead drug candidate, tecarfarin, a late-stage novel therapy with orphan drug indication for the prevention of systemic thromboembolism in patients with end-stage renal disease and atrial fibrillation. We are committed to bringing this novel therapy to the market to help improve the lives of the thousands of individuals who suffer from this very serious condition. Our mission is to build a company with a foundation of product candidates that significantly improve quality of life and patient outcomes for individuals with cardiorenal diseases.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Cadrenal Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
822 North A1A Ponte Vedra, FL 32082
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY